(Q46792246)

25 December 2017

title

Individualising treatment for older people with diabetes (English)

1 reference

25 December 2017

author name string

John E Morley

series ordinal

1

1 reference

25 December 2017

Alan Sinclair

series ordinal

2

1 reference

25 December 2017

language of work or name

English

0 references

publication date

23 May 2013

1 reference

25 December 2017

published in

The Lancet

1 reference

25 December 2017

volume

382

1 reference

25 December 2017

issue

9890

1 reference

25 December 2017

page(s)

378-380

1 reference

25 December 2017

Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diab

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961055-7

7 January 2021

Diabetes in older adults: a consensus report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961055-7

7 January 2021

Update on diabetes in the elderly and in nursing home residents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961055-7

7 January 2021

Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961055-7

7 January 2021

Developing novel therapeutic approaches to frailty

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961055-7

7 January 2021

Glycosylated hemoglobin and functional decline in community-dwelling nursing home-eligible elderly adults with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961055-7

7 January 2021

Frailty consensus: a call to action

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961055-7

7 January 2021

Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961055-7

7 January 2021

Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961055-7

7 January 2021

Autonomic imbalance: prophet of doom or scope for hope?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961055-7

7 January 2021

10.1016/S0140-6736(13)61055-7

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

23706758

1 reference

25 December 2017